ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

October 22, 2020
Case Report
Open Access

A Case of Cervical Spondylotic Amyotrophy Mimicking Amyotrophic Lateral Sclerosis

Case Reports in Neurology
Pretty Sara Idiculla, Raghav Govindarajan
October 8, 2020

ALS-Linked Mutant SOD1 Associates with TIA-1 and Alters Stress Granule Dynamics

Neurochemical Research
Do-Yeon LeeJung-Joon Sung
October 19, 2020

A review on preventive role of ketogenic diet (KD) in CNS disorders from the gut microbiota perspective

Reviews in the Neurosciences
Kajal RawatLekha Saha
October 13, 2020
Open Access

4-Cl-edaravone and (E )-2-chloro-3-[(E )-phenyldiazenyl]-2-butenoic acid are the specific reaction products of edaravone with hypochlorite

Journal of Clinical Biochemistry and Nutrition
Sakiko AmekuraAkio Fujisawa
October 20, 2020
Review

Beyond the Traditional Clinical Trials for Amyotrophic Lateral Sclerosis and The Future Impact of Gene Therapy

Journal of Neuromuscular Diseases
Marisa CappellaMaria Grazia Biferi
October 11, 2020

Neural implant for the treatment of multiple sclerosis

Medical Hypotheses
Abdorreza Naser Moghadasi
October 22, 2020

C9orf72-associated frontotemporal dementia in the Russian population

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Yu A ShpilyukovaS N Illarioshkin
October 20, 2020
Review
Open Access

Natural Compounds and Autophagy: Allies Against Neurodegeneration

Frontiers in Cell and Developmental Biology
Alessandra Stacchiotti, Giovanni Corsetti
October 3, 2020
Review

MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Lin Wang, Lijuan Zhang
October 17, 2020
Review
Open Access

Psychometric Properties of Cognitive Assessment in Amyotrophic Lateral Sclerosis: A Systematic Review

Patient Related Outcome Measures
Tina TauleTiina Rekand
October 17, 2020
Review
Open Access

Activities of Daily Living and Associated Costs in the Most Widespread Neurodegenerative Diseases: A Systematic Review

Clinical Interventions in Aging
Petra MaresovaOndrej Krejcar
October 21, 2020

Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival

Nature Neuroscience
Aude ChiotSéverine Boillée
October 11, 2020
Review

FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS

Revue neurologique
L Chen
October 21, 2020
Preprint
Open Access

Inhibitory interneurons show early dysfunction in a SOD1 mouse model of ALS

BioRxiv : the Preprint Server for Biology
C. F. CavarsanKatharina A. Quinlan
October 22, 2020

Effect of the Affordable Care Act on healthcare utilization for Veterans with spinal cord injuries and disorders

The Journal of Spinal Cord Medicine
Rachael N MartinezKevin T Stroupe
October 10, 2020
Open Access

Monocytes and neutrophils are associated with clinical features in amyotrophic lateral sclerosis

Brain Communications
Raquel B McGillTrent M Woodruff

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share a considerable proportion of characteristics including the same neuropathological substrate of abnormally phosphorylated TAR DNA binding protein (TDP-43). Here are the latest discoveries pertaining to ALS, FTD and TDP-43.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS - Stress Granules

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementias present as cognitive decline that is not a part of normal aging. Age-related dementias include Alzheimer's disease, vascular dementia, and Lewy body dementia. Discover the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/als-therapies/70cf9704-ab72-4a54-b1b1-b2e7d895a2cc